CSBR
Champions Oncology, Inc. · $5.36 (+1.7%) · mkt cap $74.5M

1 hub catalysts across 1 sources · backtest → · ← Ticker Explorer

SEC EDGAR Filings

Signal summary

Signals diverge

Bullish and bearish forces are in conflict here — weigh both columns.

30 conviction from hub signals
Bullish factors
  • 1 analyst upgrade
Bearish factors
  • 2 analyst downgrades

Best strategy

2-yr backtest · by Sharpe

RSI Mean-Reversion has fit CSBR best over 2 years (+51.7%, Sharpe 0.66). Historical/in-sample — walk-forward all 19 →

#StrategyReturnSharpeBeats B&H
1RSI Mean-Reversion+51.7%0.66
2Z-Score Mean-Reversion+40.4%0.59
3Buy & Hold (baseline)+10.1%0.43

Price — 1 year

daily close
$8.30$5.26$5.36 (-13.0% 1Y)

Analyst ratings

live · 7 changes
DateActionAnalystRating Change
2024-09-12UpgradeCraig-HallumHold → Buy
2024-03-13DowngradeCraig-HallumBuy → Hold
2019-11-18InitiatedBenchmarkSpeculative Buy
2019-09-20InitiatedRoth CapitalBuy
2019-07-24DowngradeJanney Montgomery ScottBuy → Neutral
2018-07-17InitiatedCraig-HallumBuy
2018-05-15InitiatedDawson JamesBuy

Catalyst timeline

1 hub signals
DateSourceEventEntityValue
2026-07-27SEC EDGAR Filings8-K EventCHAMPIONS ONCOLOGY, INC.source ↗
Alt-Data Signal Hub · collected signals updated 2026-07-28 09:16 UTC (refreshed daily) · market & option prices are always live on load · display-only, not advice

All pages

Catalyst EdgeCongressNewsEarningsSEC FilingsHedge FundsLockupsPositioningMarket cycleBacktestOptionsSourcesGlossaryAbout & API